Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy choices remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/tt-connects-to-miax-futures-exchanges-onyx-platform/